A controlled trial of the effect of the 5-lipoxygenase inhibitor, zileuton, on lung inflammation produced by segmental antigen challenge in human beings

Journal of Allergy and Clinical Immunology

Volumn 97, Issue 2, 1996, Pages 646-654

  Kane, Gregory C ^a   Pollice, Mary ^a   Kim, Chang Jong ^b   Cohn, Judith ^c   Dworski, Ryszard T ^d   Murray, John J ^d   Sheller, James R ^d   Fish, James E ^a   Peters, Stephen P ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b Chung Ang University   (South Korea)

^c ABBOTT LABORATORIES   (United States)

^d VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

5 lipoxygenase; bronchoalveolar lavage; cysteinyl leukotrienes; eosinophil; IgE mediated inflammation; leukotriene B4; neutrophil; SAC of the lung; zileuton

Indexed keywords

IMMUNOGLOBULIN E; LEUKOTRIENE; ZILEUTON;

ADULT; ALLERGIC PNEUMONITIS; ARACHIDONIC ACID METABOLISM; ARTICLE; CONTROLLED STUDY; EOSINOPHIL; FEMALE; HUMAN; HUMAN EXPERIMENT; INFLAMMATION; LUNG LAVAGE; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROVOCATION TEST;

EID: 0030033328     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(96)70310-X     Document Type: Article

References (31)

1. Dupuis R, Collins DS, Koh YY, et al. Effect of antigen dose on the recruitment of inflammatory cells to the lungs by segmental antigen challenge. J ALLERGY CLIN IMMUNOL 1992;89:850-7.
2. DeShazo RD, Smith DL. Bronchoalveolar lavage in asthma. Am Rev Respir Dis 1993;148:523-32.
3. Liu MC, Hubbard WC, Proud D, Stealy BA, Galli SJ, Kagey-Sobotka A, Bleecker ER, Lichtenstein LM. Immediate and late inflammation responses to ragweed antigen challenge in the peripheral airways in allergic asthmatics. Am Rev Respir Dis 1991;144:51-8.
4. Sedgwick JB, Calhoun WJ, Gleich GI, et al. Immediate and late airway response of allergic rhinitis patients to segmental antigen challenge: characterization of eosinophil and mast cell mediators. Am Rev Respir Dis 1991;144:1274-81.
5. Collins DS, Dupuis R, Gleick GJ, et al. Immunoglobulin E-mediated increase in vascular permeability correlates with eosinophil inflammation. Am Rev Respir Dis 1993; 147:677-83.
6. Ford-Hutchinson AW, Bray MA, Doig MV, Shipley ME, Smith MJH. Leukotriene B, a potent chemotactic and aggregatory substance released from polymorphonuclear leukocytes. Nature 1980;286:264-5.
7. 4. Br Med I 1983;39:249-54.
8. Samuelsson B. Leukotrienes: mediators of immediate hypersensitiyity reactions and inflammation. Science 1983; 220:568-75.
9. 4 increase the release of mucous from human airways in vitro. Am Rev Respir Dis 1982;126:449-51.
10. 4) in human skin. J Invest Dermatol 1983;80:115-9.
11. Dahlen SE, Hedquist P, Hammarstrom S, Samuelsson B. Leukotrienes are potent constrictors of human bronchi. Nature 1980;288:484-6.
12. 4. in bronchoaveolar lavage in bronchial asthma and other respiratory diseases. J ALLERGY CLIN IMMUNOL 1989;84:19-26.
13. Israel E, Dermarkarian R, Rosenberg M, et al. The effects of a 5-lipoxygenase inhibitor on asthma induced by cold, dry air. N Engl J Med 1990;323:1740-4.
14. Knapp HR. Reduced allergen-induced nasal congestion and leukotriene synthesis with an orally active 5-lipoxygenase inhibitor. N Engl J Med 1990;323:1745-8.
15. Thompson AB, Daughton D, Robbins RA, Ghafouri MA, Oehlerking M, Rennard SI. Intraluminal airway inflammation in chronic bronchitis: characterization and correlation with clinical parameters. Am Rev Respir Dis 1989;140: 1527-37.
16. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951;193:265-75.
17. Fawcett JK, Scott JE. A rapid and precise method for the determination of urea. J Clin Pathol 1960;13:156-9.
18. Chancy AL, Marback EP. Modified reagents for the estimation of ammonia in plasma. Clin Chem 1962;8:130-2.
19. Raphael GD, Druce HM, Baraniuk JN, Kaliner MA. Assessment of the sources of protein in methacholine-induced nasal secretions. Am Rev Respir Dis 1988;138:413-20.
20. Rubin P, Dubé L, Braeckman R, et al. Pharmacokinetics, safety, and ability to diminish leukotriene synthesis by zileuton, an inhibitor of 5-lipoxygenase. In: Progress in inflammation research and therapy. Basel: Birkhäuser Verlag, 1991:103-16.
21. Tagari P, Ethier D, Carry M, et al. Measurement of human urinary leukotrienes by reversed-phase liquid chromatography and radioimmunoassay. Clin Chem 1989;35:388-91.
22. Wenzel SE, Westcott JY, Smith HR, Larsen GL. Spectrum of prostanoid release after bronchoalveolar allergen challenge in atopic asthmatics and in control groups. An alteration in the ratio of bronchoconstrictive to bronchoprotective mediators. Am Rev Respir Dis 1989;139:450-7.
23. Lam S, Al-Majed S, Chan H, Tse K, LeRiche JC, ChanYeung M. Differences in mediator release between allergic rhinitis and asthma. J ALLERGY CLIN IMMUNOL 1991;87: 842-9.
24. Shaver JR, O'Connor JJ, Pollice M, et al. Pulmonary inflammation after segmental ragweed challenge in allergic asthmatics and nonasthmatics. Am J Respir Crit Care Med (in press).
25. Resnick MB, Weller PF. Mechanisms of eosinophil recruitment. Am J Respir Cell Mol Biol 1993;8:349-55.
26. 4. Am J Respir Cell Mol Biol 1993;8:493-9.
27. 4. Prostaglandins 1994;47:393-403.
28. 4 effects on human eosinophil and neutrophil motility in vitro. J Leukoc Biol 1994;55:183-90.
29. 4 and granulocyte infiltration into asthmatic airways. Lancet 1993;341:989-90.
30. Liu MC, Proud D, Lichtenstein LM, et al. Effects of prednisone on the airway inflammation following allergen challenge in subjects with allergic asthma [Abstract]. Am Rev Respir Dis 1993;147:A521.
31. Israel E, Rubin P, Kemp JP, et al. The effect of inhibition of 5-lipoxygenase by zileuton in mild-to-moderate asthma. Ann Intern Med 1993;119:10595-1066.